top of page

Literatur und Quellen

  1. Afrin LB, Molderings GJ (2014). A concise, practical guide to diagnostic assessment for mast cell activation disease. World Journal of Hematology, 3(1), S. 1-17. doi:10.5315/wjh.v3.i1.1.

  2. Afrin LB, Self S, Menk J, Lazarchick J (2017). Characterization of Mast Cell Activation Syndrome. The American Journal of the Medical Sciences, 353(3), S. 207-215. doi:10.1016/j.amjms.2016.12.013. Volltext frei verfügbar:

  3. Afrin LB, Pöhlau D, Raithel M, Haenisch B, Dumoulin FL, Homann J, Mauer UM, Harzer S, Molderings GJ (2015). Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases. Brain, Behavior, and Immunity, 50, S. 314-321. doi: 10.1016/j.bbi.2015.07.002. Abstract hier verfügar:

  4. Afrin LB (2013). Presentation, Diagnosis, and Management of Mast Cell Activation Syndrome. Mast Cells: Phenotypic Features, Biological Functions, and Role in Immunity. Happauge, NY: Nova Science Publishers, S. 155-231. Volltext frei verfügbar:

  5. Afrin LB (2014). The Presentation, Diagnosis and Treatment of Mast Cell Activation Syndrome. Current Allergy & Clinical Immunology, 27(3), S. 146-160.

  6. Molderings GJ, Homann J, Brettner S, Raithel M, Frieling T (2014). Systemische Mastzellaktivierungserkrankung: Ein praxisorientierter Leitfaden zu Diagnostik und Therapie. Deutsche Medizinische Wochenschrift, 139(30), S. 1523-1538. doi: 10.1055/s-0034-1370055. Abstract hier verfügbar:

  7. MCAS-Diagnostikcheckliste Uni Bonn,

  8. Morris ZS, Wooding S, Grant J (2011). The answer is 17 years, what is the question: understanding time lags in translational research. Journal of the Royal Society of Medicine, 104(12), S. 510–520. doi: 10.1258/jrsm.2011.110180. Volltext frei verfügbar:   

  9. Afrin LB (2016). Never Bet Against Occam: Mast Cell Activation Disease and The Modern Epidemic of Chronic Illness and Medical Complexity. Bethesda, Maryland: Sisters Media. Chapter 25: Treatment of MCAS. Hier kannst du das Buch bei Amazon kaufen: Falls du es über diesen Link kaufst, bekomme ich eine kleine Provision. Für dich kostet das nichts extra.

  10. Molderings GJ, Haenisch B, Brettner S, Homann J, Menzen M, Dumoulin FL, Panse J, Butterfield J, Afrin LB (2016). Pharmacological treatment options for mast cell activation disease. Naunyn-Schmiedeberg's Archives of Pharmacology, 389, S. 671-694, DOI 10.1007/s00210-016-1247-1. Volltext frei verfügbar:

  11. Zhang T, Finn DF, Barlow JW, Walsh JJ (2016). Mast cell stabilisers. European Journal of Pharmacology, 778, S. 158-168. doi: 10.1016/j.ejphar.2015.05.071. Epub 2015 Jun 27. Abstract hier verfügbar:

  12. Skaper SD, Facci L, Zusso M, Giusti P (2018). An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. Frontiers in Cellular Neuroscience, 12, 72. doi: 10.3389/fncel.2018.00072. Volltext frei verfügbar:

  13. Foods With the Highest Content of Quercetin, Jody Braverman, updated December 20, 2019,

  14. Peritore AF, Siracusa R, Crupi R, Cuzzocrea S (2019). Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets. Nutrients, 11(9). pii: E2175. doi: 10.3390/nu11092175. Volltext frei verfügbar:

  15. USDA/Agricultural Research Service. (2010, July 16). Luteolin stars in study of healthful plant compounds. ScienceDaily, Abgerufen am 27. März 2020,

  16. Finn DF, Walsh JJ (2013). Twenty-first century mast cell stabilizers. British Journal of Pharmacology, 170(1), 23–37. doi: 10.1111/bph.12138. Volltext frei verfügbar:

  17. Afrin LB, Ackerley MB, Bluestein LS, Brewer JH, Brook JB, Buchanan AD, Cuni JR, Davey WP, Dempsey TT, Dorff SR, Dubravec MS, Guggenheim AG, Hindman KJ, Hoffman B, Kaufman DL, Kratzer SJ, Lee TM, Marantz MS, Maxwell AJ, McCann KK, McKee DL, Menk Otto L, Pace LA, Perkins DD, Radovsky L, Raleigh MS, Rapaport SA, Reinhold EJ, Renneker ML, Robinson WA, Roland AM, Rosenbloom ES, Rowe PC, Ruhoy IS, Saperstein DS, Schlosser DA, Schofield JR, Settle JE, Weinstock LB, Wengenroth M, Westaway M, Xi SC, Molderings GJ (2020). Diagnosis of mast cell activation syndrome: a global "consensus-2". Diagnosis (Berl). pii: /j/dx.ahead-of-print/dx-2020-0005/dx-2020-0005.xml. doi: 10.1515/dx-2020-0005. Volltext frei verfügbar:

  18. COPE, Ibelgaufts H, Cytokines & Cells Online Pathfinder Encyclopaedia, Version 50.9 (Spring 2020 Edition). Molekularbiologische Datenbank.

  19. Molderings GJ (2015)The genetic basis of mast cell activation disease - looking through a glass darkly. Crit Rev Oncol Hematol 93(2):75-89. doi: 10.1016/j.critrevonc.2014.09.001. Abstract hier verfügbar:

  20. Molderings GJ (2016). Transgenerational transmission of systemic mast cell activation disease-genetic and epigenetic features. Transl Res 174:86-97. doi: 10.1016/j.trsl.2016.01.001. Abstract hier verfügbar:

  21. Zienkiewicz T, Homann J, Mücke M, Seidel H, Hertfelder HJ, Weinstock LB, Afrin LB, Molderings GJ (2023). Evaluation of a tryptase depletion index for better pathologic identification of mast cell activation syndrome. Z Gastroenterol 61(3):268-274. doi: 10.1055/a-1833-9226. Abstract hier verfügbar:

  22. Dorff SR, Afrin LB (2020). Mast cell activation syndrome in pregnancy, delivery, postpartum and lactation: a narrative review. Review J Obstet Gynaecol 40(7):889-901. doi: 10.1080/01443615.2019.1674259. Abstract hier verfügbar:

logo mastzellenhilfe.png

on social media

  • Facebook Social Icon
  • zwitschern
  • Instagram
  • RSS Social Icon


Weitere Fragen?






logo mastzellenhilfe.png

ist Mitglied bei

MCAS Hope Logo HQ (mit Rand).png


bottom of page